Health Care/Hospital
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders
* Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a$12.50 trading price * Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close * Upon closing, Baird Medical is expected to trade...
2024-03-12 19:00
2222
Bowtie partners with CUHK Medical Centre to launch the "Medical Insurance + Wellness" Package
* Full reimbursement for 360+ medical packages with transparent prices * One-stop "Medical Insurance + Wellness" solution for "Cashless Hospitalisation" experience * Yearly personalised free check-ups with targeted examinations recommended by doctors HONG KONG, March 12, 2024 /PRNewswire/ --...
2024-03-12 12:01
1545
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success
SINGAPORE, March 12, 2024 /PRNewswire/ -- From March 7 to 8, 2024, the International Society of Organoid Research (ISoOR) convened its 2024 annual meeting, after the successful conference inSingapore last year. This year, the conference was held in the vibrant city ofShanghai, China, reflecting t...
2024-03-12 11:57
1620
TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation
LUND, Sweden, March 12, 2024 /PRNewswire/ -- TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an operational base in Melbourne, Australia. This strategic move marks a significant m...
2024-03-12 10:52
1696
Mowilex Provides Interior and Exterior Paint for Pioneering Bali International Hospital
Key news highlights: * Mowilex is honored to supply paint for the Bali International Hospital, a 250-bed green facility scheduled to open in 2024. * The Indonesia Healthcare Corporation (IHC) designed the facility and its medical programs to align with global healthcare standards. * Mowilex...
2024-03-12 10:00
1679
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
SHANGHAI, March 11, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s licensing partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced that the U.S. FDA has granted an orphan drug exclusivity period of seven years for...
2024-03-12 09:28
2518
Casio to Release Uterocervical Observation Camera in the United States, Australia and New Zealand
FDA Registration Completed in the United States and TGA Approval Obtained in Australia TOKYO, March 11, 2024 /PRNewswire/ -- Casio Computer Co., Ltd. announced today that the DZ-C100 COLPOCAMERA, which is designed for uterocervical observation and photography in gynecological settings, and the C...
2024-03-12 09:00
1021
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
ROCKVILLE, Md. and SUZHOU, China, March 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmu...
2024-03-12 08:00
1763
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada
Milestone Coincides with SK Biopharmaceuticals' Global Plan Expanding Cenobamate Access to More Than 100 Markets Worldwide SEOUL, South Korea and ROME, March 12, 2024 /PRNewswire/ -- SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous system (CN...
2024-03-12 08:00
1454
Appointment of Dr Darren Patti to Group Chief Operating Officer
MELBOURNE, Australia, March 12, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce the appointment of Dr.Darren Patti as Group Chief Operating Officer (COO), effective 11 March 2024. Dr. Patti joined Telix in March 2021 to lead the Company'...
2024-03-12 05:44
1464
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
NEW YORK, March 11, 2024 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that an aggregate of$50,000 has been deposited into the Company's trust account to further extend the period of time the Company has to consummate its business combination by a...
2024-03-12 04:30
1700
Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London
SHANGHAI, March 11, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present its next generation ADC platform IDDC™ and the latest study results of multiple novel ADCs (9MW2821, 7MW3711, 9MW2921) developed...
2024-03-11 22:00
1228
Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout
BOSTON, March 11, 2024 /PRNewswire/ -- Medicilon, a one-stop pharmaceutical preclinical research and developmentCRO can simultaneously meet Chinese and American drug discovery and development needs (including GLP standards) promptly and efficiently with fast initiation times.Over the past 20 year...
2024-03-11 20:30
1169
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
OSAKA, Japan, March 11, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. ( Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it entered into a five-year, university-wide strategic research alliance agreement withHarvard University (Cambridge, MA, USA; "Harvard") aiming at v...
2024-03-11 20:00
1213
TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer
* TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab * TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co.,...
2024-03-11 20:00
1127
ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results
SEOUL, South Korea, March 11, 2024 /PRNewswire/ -- ImmunAbs, a leading clinical-stage biotechnology company focused on developing novel antibody therapeutics, today announced the successful completion of the Phase 1 clinical trial for IM-101. IM-101 is a humanized monoclonal antibody targeting...
2024-03-11 17:00
1890
AirNet Announces Changes in the Board of Directors
BEIJING, March 11, 2024 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. (the "Company") (Nasdaq: ANTE), today announced changes in its board of directors (the "Board"). Mr. Dong Wen has tendered resignation as an independent director of the Company, a member of the ...
2024-03-11 16:00
1201
Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry
SHANGHAI, March 11, 2024 /PRNewswire/ -- The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place fromApril 11th to 14th in Shanghai. The industry-leading tradeshow will draw nearly 5,000 global exhibitors from over 20 countries, with an expected audience of over 200,...
2024-03-11 15:20
1698
AI Empowers Surgery: CAIR unveils its latest large multimodality model for surgery
HONG KONG, March 11, 2024 /PRNewswire/ -- As artificial intelligence technology continues to advance, it has accelerated intelligent innovation across various industries. Breakthroughs in AI technologies like GPT have gained widespread attention, especially in the healthcare sector, where they of...
2024-03-11 15:06
1416
Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care
NEW DELHI, March 11, 2024 /PRNewswire/ -- Apollo Hospitals becomes the first hospital to introduce ZAP-X Gyroscopic Radiosurgery Platform, a significant milestone as the first inSouth Asia to introduce this ground-breaking technology. ZAP-X introduces a new era in brain tumor treatment, offering ...
2024-03-11 15:00
1541
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
7882
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
7811
Animated Life in Yunnan
2024-04-18 14:00
7781
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
6155
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3865